Pages that link to "Q48364531"

The following pages link to Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. (Q48364531):

Displaying 25 items.

• Understanding functional residues of the cannabinoid CB1. (Q27687653) (← links)
• Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors (Q33720099) (← links)
• Signal transduction of eicosanoid CB1 receptor ligands (Q33720110) (← links)
• Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. (Q33720116) (← links)
• Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. (Q33876516) (← links)
• Cannabinoid receptors and the regulation of immune response (Q34099012) (← links)
• Genetic variations in human G protein-coupled receptors: implications for drug therapy (Q34461998) (← links)
• From cannabis to cannabinergics: new therapeutic opportunities (Q34786818) (← links)
• Efficacy in CB1 receptor-mediated signal transduction (Q35047507) (← links)
• CB(1) cannabinoid receptors and their associated proteins (Q35232109) (← links)
• Cannabinoid receptors: nomenclature and pharmacological principles (Q36044310) (← links)
• Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. (Q36887138) (← links)
• The interaction of cannabinoid receptor agonists, CP58630 and WIN55212-2 with membranes using solid state 2H NMR. (Q36971357) (← links)
• Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog (Q37055254) (← links)
• A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation (Q37323369) (← links)
• The therapeutic potential of novel cannabinoid receptors (Q37402927) (← links)
• Label-Free Screening Assays: A Strategy for Finding Better Drug Candidates (Q37856304) (← links)
• CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function (Q38777382) (← links)
• The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats (Q42607871) (← links)
• 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems (Q43264679) (← links)
• (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A. (Q44392551) (← links)
• Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356). (Q52007639) (← links)
• Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells (Q73145908) (← links)
• Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators (Q90609117) (← links)
• Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure (Q90722427) (← links)